AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8783915 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone cups
Number of subjects: 72
Study 8783915 — intervention group
Group type: COMPARATOR
Intervention: Metal cups
Number of subjects: 72
Study 1462021 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized fenoterol (5 mg)
Number of subjects: 9
Study 1462021 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (5 mg)
Number of subjects: 9
Study 1462021 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (0.5 mg)
Number of subjects: 9
Study 31805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Debate on the opt-out system of organ donation
Number of subjects: 13
Study 30845197 — intervention group
Group type: EXPERIMENTAL
Intervention: Threatening message about the danger of texting while driving
Number of subjects: 0
Study 30845197 — intervention group
Group type: COMPARATOR
Intervention: Nonthreatening message
Number of subjects: 0
Study 27746377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular corticosteroid injection followed by exercise therapy
Number of subjects: 100
Study 27746377 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular saline injection followed by exercise therapy
Number of subjects: 100
Study 25553751 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 47
Study 23837414 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (aromatherapy and hand massage)
Number of subjects: 67
Study 23837414 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (3% lavender oil spray)
Number of subjects: 67
Study 23837414 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (water spray)
Number of subjects: 67
Study 21825093 — intervention group
Group type: EXPERIMENTAL
Intervention: Jin Shin Jyutsu (JSJ) treatments, 10 weekly sessions
Number of subjects: 29
Study 19242338 — intervention group
Group type: EXPERIMENTAL
Intervention: NaCl 0.9%, gelatin 4%, hydroxyethyl starch 6%, or albumin 5% loading for 90 minutes
Number of subjects: 48
Study 19242338 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloids
Number of subjects: 48
Study 19242338 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 48
Study 19242338 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloids and crystalloids
Number of subjects: 48
Study 17314262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar on 4 implants
Number of subjects: 110
Study 17314262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar on 2 implants
Number of subjects: 110
Study 17314262 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball attachments on 2 implants
Number of subjects: 110
Study 17314262 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 110
Study 15567641 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 0.1%
Number of subjects: 40
Study 15567641 — intervention group
Group type: COMPARATOR
Intervention: ropivacaine 0.2%
Number of subjects: 40
Study 11598845 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine (n=8)
Number of subjects: 14
Study 11598845 — intervention group
Group type: COMPARATOR
Intervention: Indinavir-based HAART (n=6)
Number of subjects: 14
Study 9886517 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG rod implants
Number of subjects: 1198
Study 9886517 — intervention group
Group type: COMPARATOR
Intervention: Norplant capsules
Number of subjects: 1198
Study 8027856 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus trace minerals (1000 mg elemental Ca/d, 15.0 mg zinc/d, 5.0 mg manganese/d, 2.5 mg copper/d)
Number of subjects: 59
Study 8027856 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium only (1000 mg elemental Ca/d)
Number of subjects: 59
Study 8027856 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace minerals only (15.0 mg zinc/d, 5.0 mg manganese/d, 2.5 mg copper/d)
Number of subjects: 59
Study 8027856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 2755611 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of amniotic membrane
Number of subjects: 0
Study 30698215 — intervention group
Group type: EXPERIMENTAL
Intervention: thermal mattress
Number of subjects: 75
Study 30698215 — intervention group
Group type: EXPERIMENTAL
Intervention: underbody forced‐air warming blanket
Number of subjects: 75
Study 30698215 — intervention group
Group type: EXPERIMENTAL
Intervention: heated infusion system
Number of subjects: 75
Study 28617537 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina (2 g daily for three months)
Number of subjects: 50
Study 26540973 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard decompress craniectomy and under‐temporal cranioplasty (Group A)
Number of subjects: 68
Study 26540973 — intervention group
Group type: COMPARATOR
Intervention: Modified cranioplasty with small bone chips and temporal muscle reconstruction (Group B)
Number of subjects: 68
Study 22676856 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 122
Study 22676856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 21410488 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention
Number of subjects: 150
Study 21410488 — intervention group
Group type: COMPARATOR
Intervention: General health information about alcohol consumption and fetal alcohol syndrome (Control)
Number of subjects: 150
Study 19701648 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind women
Number of subjects: 20
Study 19701648 — intervention group
Group type: COMPARATOR
Intervention: Sighted women
Number of subjects: 20
Study 19701648 — intervention group
Group type: COMPARATOR
Intervention: Sighted women (eyes closed)
Number of subjects: 20
Study 19701648 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric and concentric strength measurements
Number of subjects: 20
Study 17902008 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sertraline (25 mg/day for 2 days, then 50 mg from day 3 to 90) and buspirone (5 mg three times a day for 7 days, then 10 mg from day 8 to 90) plus cognitive-behavioral treatment
Number of subjects: 98
Study 17902008 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cognitive-behavioral treatment
Number of subjects: 98
Study 14659445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 200 mg disodium clodronate
Number of subjects: 40
Study 14659445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 200 mg disodium clodronate
Number of subjects: 40
Study 11310461 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (1 mg/kg) plus intravenous midazolam (0.1 mg/kg)
Number of subjects: 53
Study 11310461 — intervention group
Group type: COMPARATOR
Intervention: Intranasal midazolam (0.4 mg/kg)
Number of subjects: 53
Study 9135185 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (twice ED95 dose)
Number of subjects: 0
Study 9135185 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium (standard dose)
Number of subjects: 0
Study 9135185 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of rocuronium and vecuronium (equipotent dose)
Number of subjects: 0
Study 8176144 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Assessment Units (GAUs)
Number of subjects: 364
Study 8176144 — intervention group
Group type: COMPARATOR
Intervention: Community-based private physicians (CMDs)
Number of subjects: 364
Study 8176144 — intervention group
Group type: EXPERIMENTAL
Intervention: GAUs
Number of subjects: 364
Study 8176144 — intervention group
Group type: COMPARATOR
Intervention: CMDs
Number of subjects: 364
Study 3163212 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Ara-C (HiDAC)
Number of subjects: 0
Study 3163212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential asparaginase
Number of subjects: 0
Study 30654929 — intervention group
Group type: EXPERIMENTAL
Intervention: CTO PCI (n=148)
Number of subjects: 302
Study 30654929 — intervention group
Group type: COMPARATOR
Intervention: Conservative CTO treatment (n=154)
Number of subjects: 302
Study 30654929 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNTAX score above median
Number of subjects: 302
Study 27215948 — intervention group
Group type: EXPERIMENTAL
Intervention: Feldenkrais method
Number of subjects: 53
Study 27215948 — intervention group
Group type: COMPARATOR
Intervention: Back School
Number of subjects: 53
Study 25772065 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-screen (television + iPad + smartphone)
Number of subjects: 78
Study 25772065 — intervention group
Group type: COMPARATOR
Intervention: Single-screen (television)
Number of subjects: 78
Study 23649042 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate (20 mg, twice daily for 2 years)
Number of subjects: 45
Study 23649042 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 45
Study 21838909 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (ASAQ)
Number of subjects: 366
Study 21838909 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 366
Study 19707085 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated telephone interventions
Number of subjects: 8
Study 19707085 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 8
Study 18268858 — intervention group
Group type: EXPERIMENTAL
Intervention: Transilluminated powered phlebectomy (TIPP) using local tumescent anaesthesia (TA)
Number of subjects: 20
Study 15950714 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antiepileptic drug treatment
Number of subjects: 1847
Study 15950714 — intervention group
Group type: COMPARATOR
Intervention: Deferred antiepileptic drug treatment
Number of subjects: 1847
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ACE-I)
Number of subjects: 0
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (BB)
Number of subjects: 0
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II antagonists (AII-a)
Number of subjects: 0
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional antiarrhythmic drug therapy (ADT)
Number of subjects: 0
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable defibrillators (ICD)
Number of subjects: 0
Study 11790928 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BP)
Number of subjects: 0
Study 10216073 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO and G‐CSF
Number of subjects: 29
Study 10216073 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF alone
Number of subjects: 29
Study 8682055 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (12.5, 25, 50, or 75 mg per day)
Number of subjects: 1400
Study 8682055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1400
Study 2184556 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol (Tenormin)
Number of subjects: 292
Study 2184556 — intervention group
Group type: COMPARATOR
Intervention: 50 mg atenolol and 12.5 mg chlorthalidone (Tenoretic Mite)
Number of subjects: 292
Study 376390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily for 4 weeks
Number of subjects: 21
Study 376390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 376390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg daily for 1 year maintenance therapy
Number of subjects: 21
Study 376390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 21
Study 31688650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) supplementation
Number of subjects: 1635
Study 31688650 — intervention group
Group type: COMPARATOR
Intervention: Nonuser group (Control)
Number of subjects: 1635
Study 31688650 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for FO users
Number of subjects: 1635
Study 31688650 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for nonusers
Number of subjects: 1635
Study 31081565 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic dermatitis symptoms in the past year at 6.5 years
Number of subjects: 13889
Study 31081565 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma symptoms in the past year at 6.5 years
Number of subjects: 13889
Study 31081565 — intervention group
Group type: COMPARATOR
Intervention: Physician-diagnosed atopic dermatitis in the first year of life
Number of subjects: 13889
Study 29034644 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic Acid (EPA) 2 g/day for 8 weeks
Number of subjects: 36
Study 29034644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25935076 — intervention group
Group type: EXPERIMENTAL
Intervention: CwSCD
Number of subjects: 0
Study 25935076 — intervention group
Group type: COMPARATOR
Intervention: CwTLD
Number of subjects: 0
Study 22269963 — intervention group
Group type: EXPERIMENTAL
Intervention: High saturated fatty acid (SFA) diet
Number of subjects: 486
Study 22269963 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fatty acid (MUFA) diet
Number of subjects: 486
Study 22269963 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 486
Study 22269963 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat-high-n3 polyunsaturated fatty acid (PUFA) diet
Number of subjects: 486
Study 22072036 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile safety street (MSS) experience
Number of subjects: 1692
Study 22072036 — intervention group
Group type: COMPARATOR
Intervention: Traditional classroom safety curriculum
Number of subjects: 1692
Study 19143697 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Scope
Number of subjects: 20
Study 19143697 — intervention group
Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 20
Study 17061961 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem-MR 6.25 mg
Number of subjects: 24
Study 17061961 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem-MR 12.5 mg
Number of subjects: 24
Study 17061961 — intervention group
Group type: COMPARATOR
Intervention: Flurazepam 30 mg
Number of subjects: 24
Study 17061961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 15301630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic goals (community, personal growth, health) presented in an autonomy-supportive manner
Number of subjects: 0
Study 15301630 — intervention group
Group type: COMPARATOR
Intervention: Extrinsic goals (money, image) presented in a controlling manner
Number of subjects: 0
Study 15301630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic goals and autonomy support combined
Number of subjects: 0
Study 11848519 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin-based chemotherapy and irradiation
Number of subjects: 0
Study 11848519 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyurea plus irradiation or irradiation alone
Number of subjects: 0
Study 11848519 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by radical hysterectomy
Number of subjects: 0
Study 9422299 — intervention group
Group type: EXPERIMENTAL
Intervention: 2xED95 cisatracurium
Number of subjects: 24
Study 9422299 — intervention group
Group type: EXPERIMENTAL
Intervention: 4xED95 cisatracurium
Number of subjects: 24
Study 8342825 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg of 2.5% thiopental
Number of subjects: 12
Study 8342825 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 g/kg alcohol
Number of subjects: 12
Study 8342825 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study 3689105 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine in saline
Number of subjects: 11
Study 3689105 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine with phentolamine mesylate in saline
Number of subjects: 11
Study 3689105 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 11
Study 31538887 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 12
Study 31538887 — intervention group
Group type: COMPARATOR
Intervention: Combination of mitiglinide and voglibose
Number of subjects: 12
Study 30367991 — intervention group
Group type: EXPERIMENTAL
Intervention: PGx + arm (results received at baseline)
Number of subjects: 408
Study 30367991 — intervention group
Group type: COMPARATOR
Intervention: PGx - arm (results received after 12 months)
Number of subjects: 408
Study 30367991 — intervention group
Group type: EXPERIMENTAL
Intervention: PGx + arm
Number of subjects: 408
Study 30367991 — intervention group
Group type: COMPARATOR
Intervention: PGx - arm
Number of subjects: 408
Study 26928118 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-catheter approach with JL3.5
Number of subjects: 206
Study 26928118 — intervention group
Group type: COMPARATOR
Intervention: Two-catheter approach with JL3.5 and right Judkins 4.0
Number of subjects: 206
Study 24322509 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 40,000 IU
Number of subjects: 40
Study 24322509 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 40
Study 23221670 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-assisted ultrasound-guided injection
Number of subjects: 33
Study 23221670 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided injection
Number of subjects: 33
Study 22047600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrive intervention program for family day care educators; delivered over 12 months including workshops, activity exchanges, and focused discussions.
Number of subjects: 70
Study 22047600 — intervention group
Group type: COMPARATOR
Intervention: Normal work practice (Control group); no intervention activities during the initial 15 months.
Number of subjects: 70
Study 22047600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrive intervention program; assessed at baseline, 1 month, 6 months, and 12 months post-intervention.
Number of subjects: 70
Study 22047600 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrive intervention program; process evaluation at 1 month, 6 months, and 12 months post-intervention.
Number of subjects: 70
Study 18062845 — intervention group
Group type: COMPARATOR
Intervention: OROS hydromorphone 16 mg with 0% alcohol
Number of subjects: 24
Study 18062845 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 4% alcohol
Number of subjects: 24
Study 18062845 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 20% alcohol
Number of subjects: 24
Study 18062845 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS hydromorphone 16 mg with 40% alcohol
Number of subjects: 24
Study 16432681 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg
Number of subjects: 12
Study 16432681 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 25 mg
Number of subjects: 12
Study 16432681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16432681 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (both doses)
Number of subjects: 12
Study 12606507 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 0
Study 12606507 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study 10690661 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-tricalcium-phosphate-containing chewing gum (2.5% mass fraction)
Number of subjects: 14
Study 10690661 — intervention group
Group type: COMPARATOR
Intervention: conventional sugar-free gum (control)
Number of subjects: 14
Study 9212477 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 32
Study 9212477 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 32
Study 8401959 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 102
Study 8401959 — intervention group
Group type: COMPARATOR
Intervention: Supportive listening
Number of subjects: 102
Study 8401959 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (post-trial)
Number of subjects: 102
Study 8401959 — intervention group
Group type: COMPARATOR
Intervention: Control group (declined psychotherapy)
Number of subjects: 102
Study 8401959 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (one year follow-up)
Number of subjects: 102
Study 8401959 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropped out of trial
Number of subjects: 102
Study 3147046 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (opioid antagonist)
Number of subjects: 11
Study 31929371 — intervention group
Group type: EXPERIMENTAL
Intervention: IgAN patients
Number of subjects: 394
Study 30376880 — intervention group
Group type: COMPARATOR
Intervention: Bordered polyurethane dressing (BPU, standard care)
Number of subjects: 300
Study 30376880 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated securement device (ISD)
Number of subjects: 300
Study 27070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 16
Study 27070681 — intervention group
Group type: COMPARATOR
Intervention: Standard preconsultation material
Number of subjects: 16
Study 24016403 — intervention group
Group type: COMPARATOR
Intervention: Conventional Manual Wheelchair (CMW)
Number of subjects: 12
Study 24016403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic Hand Drive Mechanism (EHDM)
Number of subjects: 12
Study 24325639 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-peer teaching course
Number of subjects: 84
Study 24325639 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinical examination course
Number of subjects: 84
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR measurement at 15 min
Number of subjects: 220
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR measurement at 30 min
Number of subjects: 220
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR measurement at 60 min
Number of subjects: 220
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between 15 min and 60 min ESR measurements
Number of subjects: 220
Study 20493427 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between 30 min and 60 min ESR measurements
Number of subjects: 220